1-6 of 6
Monika Maas Enriquez
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

BAY 94-9027 Provides Safe and Effective Long-Term Prophylaxis in Pediatric Patients: Results from the PROTECT VIII Kids Extension Study

Sanjay Ahuja, MD, Kathelijn Fischer, Tina Biss, Monika Maas Enriquez, Maria-Elisa Mancuso, MacGregor Steele, MD FRCPC, Maria Wang, Gili Kenet
Journal: Blood
Blood (2020) 136 (Supplement 1): 40–41.
https://doi.org/10.1182/blood-2020-140303
Published: 2020
Journal Articles

Improvement in Quality of Life Outcomes and Bleeding Rates among Patients Switching from On-demand FVIII to Prophylactic BAY 94-9027 in the PROTECT VIII Study

Jonathan M. Ducore, MD MPH, Shadan Lalezari, PhD, Elena Santagostino, MD PhD, Sanjay P Ahuja, MD, Monika Maas Enriquez, Claudia Tueckmantel, PhD, Mark Reding
Journal: Blood
Blood (2019) 134 (Supplement_1): 1129.
https://doi.org/10.1182/blood-2019-123947
Published: 2019
Journal Articles

Correlations between von Willebrand Factor Antigen Levels and Factor VIII Pharmacokinetics Are Similar across Different FVIII Products in Patients with Severe Hemophilia A

Alfonso Iorio, Monika Maas Enriquez, Heinz Delesen, Alexander Solms, Stacy E. Croteau, Erik Berntorp
Journal: Blood
Blood (2019) 134 (Supplement_1): 3637.
https://doi.org/10.1182/blood-2019-127046
Published: 2019
Journal Articles

Rationale for Investigator-Assigned Prophylaxis Dosing Frequency in the Leopold I Study

Thomas J. Humphries, Nikki Church, Shadan Lalezari, Lone H. Poulsen, Mia Yoon, Monika Maas Enriquez
Journal: Blood
Blood (2016) 128 (22): 4984.
https://doi.org/10.1182/blood.V128.22.4984.4984
Published: 2016
Journal Articles

BAY 81-8973, a Full-Length Recombinant Factor VIII: Results from Assay Field Study

Monika Maas Enriquez, Horst Beckmann, Yvonne Katterle, Stefan Bruns, Despina Tseneklidou-Stoeter, Steve Kitchen
Journal: Blood
Blood (2015) 126 (23): 3539.
https://doi.org/10.1182/blood.V126.23.3539.3539
Published: 2015
Journal Articles

Efficacy and Safety of Secondary Prophylactic Versus On-Demand Sucrose-Formulated Recombinant Factor VIII Treatment in Adults with Severe Hemophilia A: Results from a 13-Month Crossover Study

Peter Collins, Albert Faradji, Massimo Morfini, Monika Maas Enriquez, MD, Eduard Gorina, MD, Lawrence Schwartz, Georg Lemm, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 516.
https://doi.org/10.1182/blood.V112.11.516.516
Published: 2008